Search Results 1-10 of 16462 for Huntington's+disease
This rare disease causes an early decay of nerve cells in the brain. Learn about its symptoms and how treatments may help.
Diagnosis · Neurological exam · Neuropsychological testing · Mental health evaluation · Brain-imaging and function tests · Genetic counseling and testing · Predictive ...
This test, also called an alpha-synuclein seed amplification assay, detects Parkinson's disease before symptoms begin. Alpha-synuclein clumps are a hallmark ...
Advanced diagnosis and treatment. Mayo Clinic doctors have expertise and experience in evaluating and treating people with Huntington's disease and other ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Primary endpoint is the change from baseline in the Total Motor Score (TMS) assessment of the Unified Huntington Disease Rating Scale (UHDRS) after 26 weeks of ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.